Stratifying asthma populations by medication use: how you count counts
- 31 May 2002
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (5) , 451-456
- https://doi.org/10.1016/s1081-1206(10)62381-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?Public Health, 1999
- The Unreliability of Individual Physician "Report Cards" for Assessing the Costs and Quality of Care of a Chronic DiseaseJAMA, 1999
- Asthma: Benchmarking for Quality ImprovementAnnals of Allergy, Asthma & Immunology, 1997
- Asthma Disease ManagementNew England Journal of Medicine, 1997
- Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissionsBMJ, 1996
- From Outcomes Research to Disease Management: A Guide for the PerplexedAnnals of Internal Medicine, 1996
- Disease management program for asthma: baseline assessment of resource useAmerican Journal of Health-System Pharmacy, 1996
- Drug Utilization Evaluation Identifies Costs Associated with High Use of Beta-Adrenergic AgonistsAnnals of Allergy, Asthma & Immunology, 1996
- Appropriate prescribing in asthma and its related cost in east LondonBMJ, 1995
- The Use and Abuse of Practice ProfilesNew England Journal of Medicine, 1994